share_log

JMP Securities Reiterates Market Outperform on BioAtla, Maintains $12 Price Target

Moomoo 24/7 ·  Mar 28 10:34

JMP Securities analyst Reni Benjamin reiterates BioAtla (NASDAQ:BCAB) with a Market Outperform and maintains $12 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment